Efficacy of prostate extract in the treatment of patients with chronic prostatitis caused by intracellular pathogens

Abstract

Different statistical studies showed that chronic prostatitis (CP) is the most common urological disease among men aged 20 to 40 years. The etiological nature of intracellular pathogens in the development of CP is currently finding more and more evidence. The prostate extract acting on various pathogenesis units is of particular interest, taking into account the variety of pathogenetic mechanisms of the development of CP. A study of the efficacy and safety of prostate extract (rectal suppositories) combined with josamycin was conducted. Findings. Patients with CP caused by intracellular pathogens received josamycin therapy. The prostate extract was included in the treatment (rectal suppositories) in Group I. Both groups showed a significant improvement in symptoms and quality of life on the NIH-CPSI scale, both in total and in individual domains, and the differences between the groups were statistically insignificant. The number of leukocytes in the prostate gland secret reduced more significantly in the active treatment group.Thus, the use of prostate extract increased the clinical efficacy of treatment, which correlates with data from the previous studies.

Keywords

• chronic prostatitis
• prostate extract
• josamycin
• antibacterial therapy